FAQ
Szukaj
Użytkownicy
Grupy
Galerie
Rejestracja
Profil
Zaloguj się, by sprawdzić wiadomości
Zaloguj
Forum powered by pafell Strona Główna
->
Rozmowy
Napisz odpowiedź
Użytkownik
Temat
Treść wiadomości
Emotikony
Więcej Ikon
Kolor:
Domyślny
Ciemnoczerwony
Czerwony
Pomarańćzowy
Brązowy
Żółty
Zielony
Oliwkowy
Błękitny
Niebieski
Ciemnoniebieski
Purpurowy
Fioletowy
Biały
Czarny
Rozmiar:
Minimalny
Mały
Normalny
Duży
Ogromny
Zamknij Tagi
Opcje
HTML:
NIE
BBCode
:
TAK
Uśmieszki:
NIE
Wyłącz BBCode w tym poście
Kod potwierdzający: *
Wszystkie czasy w strefie EET (Europa)
Skocz do:
Wybierz forum
Strona!
----------------
Program posiada nową stronę WWW!
Regulamin, legenda, wymagania
----------------
Komunikaty
Regulamin
Legenda
Wymagania
App (Application Manager)
----------------
Download
Komunikaty
Rozmowy
Budzik
----------------
Download
Komunikaty
Rozmowy
pafell_uptader
----------------
Download
Komunikaty
Rozmowy
Out of topic
----------------
Off-topic
Przegląd tematu
Autor
Wiadomość
v4zmkw27vh
Wysłany: Wto 12:45, 29 Mar 2011
Temat postu: PPD Acquires Two Research Organizations in China
PPD Inc. has announced two deals in as many days.
The Wilmington-based contract research organization said Wednesday that it has agreed to acquire BioDuro LLC in a move that will expand its drug capabilities in China.
BioDuro, described as a drug discovery outsourcing company, operates a laboratory in Beijing. Most of its 660 employees are based in China, PPD said.
When the deal closes, expected in the fourth quarter, PPD will employ nearly 1,000 in China, making it the largest CRO to offer clinical development and discovery services in that country, the company said.
PPD and BioDuro will perform research and development services for large pharmaceutical clients from early stage through Phase IV development.
PPD cited Barclays Capital as saying biopharmaceutical companies spend $20.2 billion on drug discovery research annually. Of that, $1.6 billion is outsourced now, but that is expected to grow to $5 billion to $10 billion in the next three to five years.
The BioDuro deal will position PPD "to be the full-service CRO of choice in China," CEO David Grange said in a statement.
Additionally,
mobile development outsourcing
, PPD recently acquired Excel PharmaStudies, the market leader and one of the largest CROs in China.
On Tuesday,
Software Localization
, PPD said it will collaborate with Janssen Pharmaceutia N.V. to develop and commercialize two compounds, one to treat diarrhea-predominant irritable bowel syndrome and the other to treat complicated skin and skin structure and respiratory infections.
Under the agreement, PPD could receive millions of dollars in milestone payments and royalties.
PPD said it will advance the compounds through Phase II development. When Phase II is completed,
Pharmaceutical software
, Janssen will have the option to develop and commercialize the compounds.
In exchange, PPD would receive up to $330 million in clinical and sales milestones and royalties on sales of the compounds if they are approved for marketing.
fora.pl
- załóż własne forum dyskusyjne za darmo
Powered by
phpBB
© 2001, 2005 phpBB Group
Theme
xand
created by
spleen
&
Emule
.
Regulamin